Janssen/ $JNJ dropped its 2019 Transparency Report. Come for the disclosures (list prices up 5.1%, net prices down 1.2%), stay for the exhaustive description of economics of pharmaceuticals. 

Not a client, but -- as always -- impressed with the work.

https://t.co/QqD8xR7UQL